Archive.fm

Wall Street Breakfast

Biomea Climbs on Diabetes Drug Data

Biomea (BMEA) climbs on Phase 2 data for Type 2 diabetes candidate. (00:42) Ermotti returns as UBS (UBS) CEO to guide Credit Suisse (CS) deal (01:45). AMC (AMC) jumps on report Amazon (AMZN) exploring potential acquisition (updated) (06:40).

Our links:

Wall Street Breakfast: seekingalpha.com/wsb
Seeking Alpha's Wall Street Breakfast brings the top news to investors every morning. Released by 8:00am ET, it's all the news you need to know for your market day.

Seeking Alpha Premium: https://seekingalpha.com/premium/getting-started
A comprehensive set of features and analysis that helps take the guesswork out of your investing decisions. Get the bottom-line on any stock or ETF with our Premium tools.

Alpha Picks: https://seekingalpha.com/alpha-picks/subscribe
Alpha Picks gives you two top stock picks each month, sifted from Seeking Alpha’s analysis of thousands of stocks. We do the work. You reap the rewards.

Twitter: https://twitter.com/WallStBreakfast

Show links:

Brad Thomas: https://seekingalpha.com/author/brad-thomas
Investing Experts podcast with Brad Thomas
VICI Properties: https://seekingalpha.com/symbol/VICI
Microsoft debuts new AI chatbot for cybersecurity needs
Lucid reportedly plans to lay off nearly 1300 workers
Lucid Group: Not Healthy, But Has A Few Ways To Cheat Death
Apple rolls out new Buy Now, Pay Later option in U.S.
N-able jumps 8% on addition to SmallCap 600 index
Chinese edtech NetClass files for proposed $17M US IPO
Skincare products developer CoLabs files for proposed $6M IPO
Nike opens Jordan brand store in Japan

Broadcast on:
29 Mar 2023